{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:10:21Z","timestamp":1791360621334,"version":"4.3.1"},"reference-count":130,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Endometrial cancer (EC) is the most common cancer affecting the female reproductive organs in higher-income states. Apart from reproductive factors and excess weight, genetic predisposition is increasingly recognized as a major factor in endometrial cancer risk. Endometrial cancer is genetically heterogeneous: while a subgroup of patients belongs to cancer predisposition syndromes (most notably the Lynch Syndrome) with high to intermediate lifetime risks, there are also several common genomic polymorphisms contributing to the spectrum of germline predispositions. Germline variants and somatic events may act in concert to modulate the molecular evolution of the tumor, where mismatch-repair deficiency is common in endometrioid endometrial tumors whereas homologous recombinational repair deficiency has been described for non-endometrioid endometrial tumors. In this review, we will survey the currently known genomic predispositions for endometrial cancer and discuss their relevance for clinical management in terms of counseling, screening and novel treatments.<\/jats:p>","DOI":"10.3390\/cancers12092407","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T09:24:56Z","timestamp":1598347496000},"page":"2407","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Genetic Susceptibility to Endometrial Cancer: Risk Factors and Clinical Management"],"prefix":"10.3390","volume":"12","author":[{"given":"Thilo","family":"D\u00f6rk","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, Comprehensive Cancer Center, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9829-3531","authenticated-orcid":false,"given":"Peter","family":"Hillemanns","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Comprehensive Cancer Center, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6904-3258","authenticated-orcid":false,"given":"Clemens","family":"Tempfer","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, Marien-Hospital, Ruhr University of Bochum, 44625 Herne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Breu","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University of Witten\/Herdecke, 42283 Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus C.","family":"Fleisch","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University of Witten\/Herdecke, 42283 Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Olson, S.H., Jewell, E., and Rastogi, R.M. (2013). Endometrial Cancer. Women and Health, Elsevier. [2nd ed.].","DOI":"10.1016\/B978-0-12-384978-6.00076-5"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10689-014-9722-7","article-title":"Genetics of endometrial cancer","volume":"13","author":"Shai","year":"2014","journal-title":"Fam. Cancer"},{"key":"ref_5","unstructured":"Pollack, R.E. (1999). Gynaecologic Cancer. UICC International Union against Cancer Manual of Clinical Oncology, Wiley. [7th ed.]."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","article-title":"Cancer incidence and mortality in relation to body mass index in the million women study: Cohort study","volume":"335","author":"Reeves","year":"2007","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1210\/en.2009-1334","article-title":"Reepithelialization of the uterine surface arises from endometrial glands: Evidence from a functional mouse model of breakdown and repair","volume":"151","author":"Ye","year":"2010","journal-title":"Endocrinology"},{"key":"ref_9","first-page":"137","article-title":"Endometrial stem\/progenitor cells: The first 10 years","volume":"22","author":"Gargett","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"ref_10","first-page":"963","article-title":"Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas","volume":"10","author":"Sherman","year":"1997","journal-title":"Mod. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: Have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, Kandoth, C., Schultz, N., Cherniack, A.D., Akbani, R., Liu, Y., Shen, H., Robertson, A.G., Pashtan, I., and Shen, R. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497, 67\u201373.","DOI":"10.1038\/nature12113"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.celrep.2018.07.037","article-title":"Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium","volume":"24","author":"Suda","year":"2018","journal-title":"Cell Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cell.2020.01.026","article-title":"Clinical Proteomic Tumor Analysis Consortium. Proteogenomic Characterization of Endometrial Carcinoma","volume":"180","author":"Dou","year":"2020","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41586-020-2214-z","article-title":"The mutational landscape of normal human endometrial epithelium","volume":"580","author":"Moore","year":"2020","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/d41586-020-01081-6","article-title":"A catalogue of cancer-driving mutations in healthy tissue","volume":"580","author":"Levine","year":"2020","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pathol.2015.11.003","article-title":"Early changes of endometrial neoplasia revealed by loss of mismatch repair gene protein expression in a patient diagnosed with Lynch syndrome","volume":"48","author":"McKenzie","year":"2016","journal-title":"Pathology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/AOG.0000000000000563","article-title":"Family history and risk of endometrial cancer: A systematic review and meta-analysis","volume":"125","author":"Win","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ygyno.2017.08.011","article-title":"Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling","volume":"147","author":"Johnatty","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer\u2013analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1093\/hmg\/ddu312","article-title":"Most common \u2018sporadic\u2019 cancers have a significant germline genetic component","volume":"23","author":"Lu","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial risk and heritability of cancer among twins in Nordic countries","volume":"315","author":"Mucci","year":"2016","journal-title":"J. Am. Med. Assoc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2009.01230.x","article-title":"Review of the Lynch syndrome: History, molecular genetics, screening, differential diagnosis, and medicolegal ramifications","volume":"76","author":"Lynch","year":"2009","journal-title":"Clin. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ygyno.2009.03.003","article-title":"Current and emerging trends in Lynch syndrome identification in women with endometrial cancer","volume":"114","author":"Resnick","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/modpathol.2017.20","article-title":"Endometrial cancer gene panels: Clinical diagnostic vs research germline DNA testing","volume":"30","author":"Spurdle","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1158\/1055-9965.EPI-18-1031","article-title":"Genome-Wide Association Studies of Endometrial Cancer: Latest Developments and Future Directions","volume":"28","author":"Glubb","year":"2019","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/path.5422","article-title":"Molecular pathology of Lynch syndrome","volume":"250","author":"Cerretelli","year":"2020","journal-title":"J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archinte.1913.00070050063006","article-title":"Heredity with reference to carcinoma","volume":"12","author":"Warthin","year":"1913","journal-title":"Arch. Intern. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archinte.1966.03870080050009","article-title":"Hereditary factors in cancer: Study of two large Midwestern kindreds","volume":"117","author":"Lynch","year":"1966","journal-title":"Arch. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","article-title":"Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: A report from the prospective Lynch syndrome database","volume":"67","author":"Bernstein","year":"2018","journal-title":"Gut"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","article-title":"Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: Findings from the prospective Lynch syndrome database","volume":"22","author":"Sampson","year":"2020","journal-title":"Genet. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2014.01.017","article-title":"Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables","volume":"133","author":"Perrino","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.bi.65.070196.000533","article-title":"Mismatch repair in replication fidelity, genetic recombination, and cancer biology","volume":"65","author":"Modrich","year":"1996","journal-title":"Annu. Rev. Biochem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.semcancer.2010.10.009","article-title":"DNA replication fidelity and cancer","volume":"20","author":"Preston","year":"2010","journal-title":"Semin. Cancer Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ng1052","article-title":"The mismatch repair system is required for S-phase checkpoint activation","volume":"33","author":"Brown","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.dnarep.2004.06.006","article-title":"Mismatch repair and DNA damage signalling","volume":"3","author":"Stojic","year":"2004","journal-title":"DNA Repair"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.molcel.2006.04.023","article-title":"ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts","volume":"22","author":"Yoshioka","year":"2006","journal-title":"Mol. Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2013.51.2129","article-title":"Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing","volume":"32","author":"Buchanan","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/s41379-020-0501-8","article-title":"Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma","volume":"33","author":"Pasanen","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/gcc.20678","article-title":"Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome","volume":"48","author":"Niessen","year":"2009","journal-title":"Genes Chromos. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1470-2045(10)70265-5","article-title":"Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: A cohort study","volume":"12","author":"Kempers","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/humu.21617","article-title":"Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility","volume":"33","author":"Dieu","year":"2012","journal-title":"Hum. Mutat."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jmedgenet-2017-104744","article-title":"Comprehensive analysis of the MLH1 promoter region in 480 patients with colorectal cancer and 1150 controls reveals new variants including one with a heritable constitutional MLH1 epimutation","volume":"55","author":"Morak","year":"2018","journal-title":"J. Med. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/GIM.0b013e31821dd525","article-title":"A novel exonic rearrangement affecting MLH1 and the contiguous LRRFIP2 is a founder mutation in Portuguese Lynch syndrome families","volume":"13","author":"Pinheiro","year":"2011","journal-title":"Genet. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/jmedgenet-2011-100050","article-title":"Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome","volume":"48","author":"Morak","year":"2011","journal-title":"J. Med. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1158\/1078-0432.CCR-08-1908","article-title":"An interstitial deletion at 3p21.3 results in the genetic fusion of MLH1 and ITGA9 in a Lynch syndrome family","volume":"15","author":"Meyer","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10689-008-9225-5","article-title":"A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts","volume":"8","author":"Sjursen","year":"2009","journal-title":"Fam. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/jmedgenet-2013-102238","article-title":"Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium \u201cCare for CMMR-D\u201d (C4CMMR-D)","volume":"51","author":"Vasen","year":"2014","journal-title":"J. Med. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/jmedgenet-2015-103299","article-title":"Constitutional mismatch repair deficiency syndrome: Clinical description in a French cohort","volume":"52","author":"Lavoine","year":"2015","journal-title":"J. Med. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1200\/JCO.2014.57.8088","article-title":"Lynch syndrome caused by germline PMS2 mutations: Delineating the cancer risk","volume":"33","author":"Brohet","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/cge.13205","article-title":"The changing landscape of Lynch syndrome due to PMS2 mutations","volume":"94","author":"Blount","year":"2018","journal-title":"Clin. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/s41436-019-0489-y","article-title":"The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome","volume":"21","author":"Crosbie","year":"2019","journal-title":"Genet. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/01.pas.0000213428.61374.06","article-title":"Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma","volume":"31","author":"Modica","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-58-1-136","article-title":"Cowden\u2019s disease. A possible new symptom complex with multiple system involvement","volume":"58","author":"Lloyd","year":"1963","journal-title":"Ann. Intern. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ng0596-114","article-title":"Localization of the gene for Cowden disease to chromosome 10q22-23","volume":"13","author":"Nelen","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ng0597-64","article-title":"Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome","volume":"16","author":"Liaw","year":"1997","journal-title":"Nat. Genet."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Pilarski, R. (2019). PTEN Hamartoma Tumor Syndrome: A Clinical Overview. Cancers, 11.","DOI":"10.3390\/cancers11060844"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jso.23735","article-title":"Cowden syndrome: Recognizing and managing a not so-rare hereditary cancer syndrome","volume":"111","author":"Mester","year":"2015","journal-title":"J. Surg. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jmedgenet-2012-101339","article-title":"French Cowden Disease Network. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome","volume":"50","author":"Bubien","year":"2013","journal-title":"J. Med. Genet."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10689-013-9674-3","article-title":"Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome","volume":"13","author":"Nieuwenhuis","year":"2013","journal-title":"Fam. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gynor.2012.10.006","article-title":"Endometrial cancer in a 15-year-old girl: A complication of Cowden syndrome","volume":"3","author":"Elnaggar","year":"2012","journal-title":"Gynecol. Oncol. Case Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1447-0756.2012.02052.x","article-title":"Endometrial cancer in a 14-year old girl with Cowden syndrome: A case report","volume":"39","author":"Baker","year":"2013","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Mutter","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/modpathol.2013.67","article-title":"Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: Retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas","volume":"26","author":"Djordjevic","year":"2013","journal-title":"Mod. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ygyno.2004.09.024","article-title":"Evaluation of germline PTEN mutations in endometrial cancer patients","volume":"96","author":"Black","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajhg.2012.10.021","article-title":"Germline PIK3CA and AKT1 Mutations in Cowden and Cowden-like Syndromes","volume":"92","author":"Orloff","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ng.2503","article-title":"Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas","volume":"45","author":"Palles","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/ejhg.2014.242","article-title":"Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer","volume":"23","author":"Elsayed","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3892\/ijo.2014.2410","article-title":"A mutation in POLE predisposing to a multi-tumour phenotype","volume":"45","author":"Rohlin","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/gim.2015.75","article-title":"POLE and POLD1 mutations in 529 kindreds with familial colorectal cancer and\/or polyposis: Review of reported cases and recommendations for genetic testing and surveillance","volume":"18","author":"Bellido","year":"2016","journal-title":"Genet. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12935-019-1058-9","article-title":"Germline POLE and POLD1 proofreading domain mutations in endometrial carcinoma from Middle Eastern region","volume":"19","author":"Siraj","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ajhg.2018.10.024","article-title":"DNA Polymerase Epsilon Deficiency Causes IMAGe Syndrome with Variable Immunodeficiency","volume":"103","author":"Logan","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1084\/jem.20121303","article-title":"Polymerase \u03b51 mutation in a human syndrome with facial dysmorphism, immunodeficiency, livedo, and short stature (\u201cFILS syndrome\u201d)","volume":"209","author":"Lemoine","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1053\/j.gastro.2014.01.022","article-title":"Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer","volume":"146","author":"Win","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1053\/j.gastro.2009.08.052","article-title":"Expanded extracolonic tumor spectrum in MUTYH-associated polyposis","volume":"137","author":"Vogt","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/ijc.30197","article-title":"Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH","volume":"139","author":"Win","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.3287","article-title":"A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer","volume":"47","author":"Weren","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ccell.2018.12.011","article-title":"Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype","volume":"35","author":"Grolleman","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer Incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2006.08.004","article-title":"The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study","volume":"104","author":"Beiner","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2013.03.027","article-title":"The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: An international prospective cohort study","volume":"130","author":"Segev","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamaoncol.2016.1820","article-title":"Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations","volume":"2","author":"Shu","year":"2016","journal-title":"JAMA Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.1158\/1078-0432.CCR-19-0848","article-title":"Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity","volume":"25","author":"Ritterhouse","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.812","article-title":"Genome-wide association study identifies a common variant associated with risk of endometrial cancer","volume":"43","author":"Spurdle","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_87","first-page":"2612","article-title":"GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer","volume":"25","author":"Chen","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ng.3562","article-title":"Five endometrial cancer risk loci identified through genome-wide association analysis","volume":"48","author":"Cheng","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1038\/s41467-018-05427-7","article-title":"Identification of nine new susceptibility loci for endometrial cancer","volume":"9","author":"Glubb","year":"2018","journal-title":"Nat. Comm."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ajhg.2016.04.012","article-title":"A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding","volume":"98","author":"Painter","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"17369","DOI":"10.1038\/srep17369","article-title":"Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1","volume":"5","author":"Cheng","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/cam4.1445","article-title":"Genetic overlap between endometriosis and endometrial cancer: Evidence from cross-disease genetic correlation and GWAS meta-analyses","volume":"7","author":"Painter","year":"2018","journal-title":"Cancer Med."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"O\u2019Mara, T.A., and Crosbie, E.J. (2020). Polygenic risk score opportunities for early detection and prevention strategies in endometrial cancer. Br. J. Cancer, in press.","DOI":"10.1038\/s41416-020-0959-7"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Nead, K.T., Sharp, S.J., Thompson, D.J., Painter, J.N., Savage, D.B., Semple, R.K., Barker, A., Australian National Endometrial Cancer Study Group (ANECS), Perry, J.R., and Attia, J. (2015). Evidence of a causal association between insulinemia and endometrial cancer: A mendelian randomization analysis. J. Natl. Cancer Inst., 107.","DOI":"10.1093\/jnci\/djv178"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1158\/1055-9965.EPI-16-0147","article-title":"Genetic risk score Mendelian randomization shows that obesity measured as body mass index, but not waist:hip ratio, is causal for endometrial cancer","volume":"25","author":"Painter","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1530\/ERC-15-0386","article-title":"CYP19A1 fine-mapping and Mendelian randomization: Estradiol is causal for endometrial cancer","volume":"23","author":"Thompson","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_97","unstructured":"Kho, P.-F., Amant, F., Annibali, D., Ashton, K., Attia, J., Auer, P.L., Beckmann, M.W., Black, A., Brinton, L., and Buchanan, D.D. (2020). Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer. Int. J. Cancer, in press."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.AOG.0000154885.44002.ae","article-title":"Gynecologic cancer as a \u201csentinel cancer\u201d for women with hereditary nonpolyposis colorectal cancer syndrome","volume":"105","author":"Lu","year":"2005","journal-title":"Obstet Gynecol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1200\/JCO.2004.11.084","article-title":"Refining the Amsterdam Criteria and Bethesda Guidelines: Testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic","volume":"22","author":"Lipton","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Egoavil, C., Alenda, C., Castillejo, A., Paya, A., Peiro, G., S\u00e1nchez-Heras, A.B., Castillejo, M.I., Rojas, E., Barber\u00e1, V.M., and Cig\u00fcenza, S. (2013). Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079737"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1002\/cncr.28933","article-title":"Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing","volume":"120","author":"Ferguson","year":"2014","journal-title":"Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1158\/0008-5472.CAN-06-1114","article-title":"Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients","volume":"66","author":"Hampel","year":"2006","journal-title":"Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"9603","DOI":"10.1158\/0008-5472.CAN-07-2308","article-title":"Comment on: Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients","volume":"67","author":"Hampel","year":"2007","journal-title":"Cancer Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ygyno.2012.01.049","article-title":"Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer \u2264 70 years","volume":"125","author":"Leenen","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18580","article-title":"A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome","volume":"18","author":"Snowsill","year":"2014","journal-title":"Health Technol. Assess."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ygyno.2009.05.026","article-title":"Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer","volume":"114","author":"Backes","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2013.04.022","article-title":"Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center","volume":"130","author":"Moline","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/ejhg.2011.277","article-title":"MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: A cost-effectiveness study","volume":"20","author":"Gausachs","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1158\/1078-0432.CCR-1118-3","article-title":"BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer","volume":"10","author":"Deng","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_110","first-page":"1541","article-title":"Analysis of a correlation between the BRAF V600E mutation and abnormal DNA mismatch repair in patients with sporadic endometrial cancer","volume":"34","author":"Kawaguchi","year":"2009","journal-title":"Int. J. Oncol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/cncr.10380","article-title":"The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma","volume":"94","author":"Boks","year":"2002","journal-title":"Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0090-8258(03)00371-8","article-title":"Gynecologic screening in hereditary nonpolyposis colorectal cancer","volume":"91","author":"Rijcken","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0412.2011.01091.x","article-title":"A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families","volume":"90","author":"Auranen","year":"2011","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_114","first-page":"821","article-title":"Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome","volume":"120","author":"Leminen","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1525-1438.2007.01183.x","article-title":"Performance of office hysteroscopy and endometrial biopsy for detecting endometrial disease in women at risk of human non-polyposis colon cancer: A prospective study","volume":"18","author":"Bats","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00404-012-2492-2","article-title":"Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC\/Lynch syndrome (LS)","volume":"286","author":"Manchanda","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2013.05.032","article-title":"The additional value of endometrial sampling in the early detection of endometrial cancer in women with Lynch syndrome","volume":"131","author":"Sijmons","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jamaoncol.2017.0619","article-title":"Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies","volume":"3","author":"Ryan","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","article-title":"Revised guidelines for the clinical management of Lynch syndrome (HNPCC): Recommendations by a group of European experts","volume":"62","author":"Vasen","year":"2013","journal-title":"Gut"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/PAS.0000000000000684","article-title":"Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome","volume":"40","author":"Bartosch","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.path.2016.02.002","article-title":"Prophylactic gynecologic specimens from hereditary cancer carriers","volume":"9","author":"Shaw","year":"2016","journal-title":"Surg. Pathol. Clin."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.3389\/fimmu.2019.03023","article-title":"Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer","volume":"10","author":"Ramchander","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Bohaumilitzky, L., von Knebel Doeberitz, M., Kloor, M., and Ahadova, A. (2020). Implications of Hereditary Origin on the Immune Phenotype of Mismatch Repair-Deficient Cancers: Systematic Literature Review. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061741"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1200\/JCO.2017.72.5952","article-title":"Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study","volume":"35","author":"Ott","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S1470-2045(19)30020-8","article-title":"Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: An interim analysis of a multicentre, open-label, single-arm, phase 2 trial","volume":"20","author":"Makker","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"53ra75","DOI":"10.1126\/scitranslmed.3001538","article-title":"PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors","volume":"2","author":"Dedes","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/onc.2017.326","article-title":"PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy","volume":"37","author":"Bian","year":"2018","journal-title":"Oncogene"},{"key":"ref_129","unstructured":"(2020, May 27). U.S. National Library of Medicine, ClinicalTrials.gov Database, Available online: https:\/\/www.clinicaltrials.gov\/."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1078-0432.CCR-18-1443","article-title":"Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas","volume":"25","author":"Auguste","year":"2019","journal-title":"Clin. Cancer Res."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/9\/2407\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:06:09Z","timestamp":1760177169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/9\/2407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":130,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["cancers12092407"],"URL":"https:\/\/doi.org\/10.3390\/cancers12092407","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]}}}